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Introduction
The establishment of human induced pluripotent stem cells (iPSCs) has 
revealed a new path for the generation of stem cells without the use of 
embryos. This new approach eliminates ethical concerns and provides an 
invaluable contribution to the fi eld of regenerative medicine and stem cell 
biology. The direct reprogramming of somatic cells to pluripotency was fi rst 
accomplished in 2006, when Takahashi and Yamanaka converted adult mouse 
fi broblasts to iPSCs through ectopic expression of a select group of 
transcription factors1. Subsequent reports optimized this technique, 
demonstrating that regardless of the gene combination used iPSCs were highly 
similar to embryonic stem cells (ESCs) in their morphology, ability to express 
cell surface markers typical of pluripotent cells, form viable chimeras, and give 
rise to teratomas containing cell types representative of all three germ layers2,3.
Human ES and iPS cells require a specifi c culture system for successful 
expansion. Originally, human ES cells were cultured on a feeder layer of 
mouse embryonic fi broblasts (MEFs). While MEFs provide a robust surface for 
long-term culture of hES cells, there are a number of concerns associated with 
the use of a cell feeder layer. Feeder cells may secrete undefi ned components 
into the media and cause batch-to-batch variability in feeder layers, or there 
may be xenogenic contamination of hES and hiPS cells grown in this system. 
BD Matrigel™ matrix is a well established growth substrate for feeder-free 
hES culture. Recently, BD Matrigel matrix has been used for culturing 
undifferentiated human iPS cells in a feeder-free environment. This has been 
accomplished using BD Matrigel matrix in conjunction with MEF- 
conditioned medium, culture additives or defi ned media such as mTeSR®1 
(STEMCELL Technologies), and for in vivo differentiation studies eg, 
teratoma formation4–6. BD Matrigel™ matrix is a reconstituted basement 
membrane isolated from the Engelbreth-Holm-Swarm mouse sarcoma and 
contains extracellular matrix molecules such as laminin, collagen IV, entactin, 
and heparan sulfate proteoglycan7. It is highly biologically active and closely 
resembles basement membrane in both consistency and activity8. STEMCELL 
Technologies has developed mTeSR1 and TeSR™2 as standardized media for 
feeder-independent maintenance of human pluripotent stem cells (hPSCs). 
These media formulations have been designed to maintain and expand 
undifferentiated hPSCs in conjunction with BD Matrigel™ hESC qualifi ed 
matrix (BD Cat. No. 354277) as a growth substrate. Furthermore, each batch 
of BD Matrigel hESC qualifi ed matrix is pre-qualifi ed by STEMCELL 
Technologies to ensure consistency, reproducibility, and reliability in 
performance.
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Disclaimer
Human iPS cells were fi rst established using inactivated MEFs and hESC 
media, but subsequently shown to grow well in a feeder-free system using 
BD Matrigel™ matrix and mTeSR®. When using the MEF feeder layer 
method a higher replating effi ciency is achieved when picking iPSC colony. 
The disadvantage of this approach is that many colonies emerge from partially 
reprogrammed cells, which may not be easy to distinguish from true human 
iPS colonies. The BD Matrigel matrix and mTeSR feeder-free system is a more 
stringent culture method that more clearly distinguishes true human iPS cells 
from partially reprogrammed cells9.
This report details the feeder independent culture method for adult human iPS 
cells using BD Matrigel hESC-qualifi ed matrix and mTeSR1 media, thus 
eliminating concerns regarding batch-to-batch variability associated with 
feeder layers. A variety of methods exist for iPS cell derivation, all reliant upon 
manipulation of a select group of transcription factors10. A human iPS cell 
clone derived from myoblasts (clone C5-139) was established by transduction 
of retroviral expressed factors including Oct4, Sox2, Klf4, in combination 
with lentiviral vectors expressing lgT and cMyc. In this study, we demonstrate 
the maintenance of undifferentiated iPS cells on BD Matrigel hESC-qualifi ed 
matrix once the round(s) of infection have been completed, and several 
colonies have appeared on MEF layer. The iPS cells grown on BD Matrigel 
matrix in mTeSR1 media exhibit undifferentiated colony morphology, express 
markers of undifferentiated iPS cells, and maintain pluripotency after 30 
passages. Cells were able to form teratomas and differentiate into the cells of 
all three-germ layers.
Materials and Methods
Reagents
• BD Matrigel hESC-qualifi ed matrix (BD Cat. No. 354277) and 
BD™ Dispase (BD Cat. No. 354235).
• For immunocytochemistry, human embryonic stem cell marker antibody 
panel (R&D Systems Cat. No. SC008).
• TRA-1-60 (EMD Millipore Cat. No. MAB4360).
• Alexa Fluor® 555 donkey anti-goat IgG (Life Technologies Cat. No. 
A21432), and Alexa Fluor 555 goat anti-mouse IgG (Life Technologies 
Cat. No. A21422) secondary antibodies.
• mTeSR media (STEMCELL Technologies Cat. No. 05850).
• Accumax (EMD Millipore Cat. No. SCR006).
• Penicillin-Streptomycin (Gibco Cat. No. 15070-063).
Preparation of mTeSR Media
The components of mTeSR media: mTeSR Basal Media and 5X mTeSR 
Supplement were mixed according to the recommendations in the product 
specifi cation sheet. Penicillin-Streptomycin was added to the mTeSR media. 
For optimal results, the lot numbers of both components of the mTeSR1 
Medium kit (mTeSR1 Basal Medium and mTeSR1 5X Supplement) should end 
with the same letter (eg, D). If desired, 5X Supplement can be aseptically 
dispensed into working aliquots and stored at -20ºC. Frozen aliquots were 
used within 3 months. Thawed aliquots should be used within 1 day to 
prepare complete mTeSR1 medium.
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Coating Procedure
BD Matrigel™ hESC-qualifi ed matrix was thawed on ice according to the 
recommendations provided in the product specifi cation sheet. Repeated freeze 
thaw is not recommended. For coating, one aliquot of BD Matrigel 
hESC-qualifi ed matrix was added to 25 mL ice-cold DMEM/F-12 
(HyClone™, Thermo Fisher). Instructions for aliquot volume is lot-specifi c 
based on the protein concentration and is found on the product specifi cation 
sheet, as well as on the BD Biosciences support webpage. The coating solution 
was kept on ice at all times. One mL of the coating solution was added to each 
well of a BD Falcon™ 6-well multiwell plate (kept on ice) and spread by 
rocking gently (if air bubbles get trapped in the wells, centrifuge the plate at 
300 x g for 10 minutes at 4°C. The centrifuge should be pre-cooled to 4ºC). 
Plates were incubated at room temperature for 1-2 hours. The coating solution 
was aspirated from the plate, and cells were plated. Coated plates with coating 
solution can be stored at 4ºC and should be used within one week of coating. 
Coating solution should be aspirated just before using the plates.
Picking Colonies
Once the round(s) of infection has been completed, and several colonies 
appeared on the the MEF layer, the colonies were passaged using BD™ 
Dispase once or twice until clear, human ES-like colonies appear. Once clear 
colonies have appeared on MEF layer, they were picked to establish a clonal 
population. Colonies to be picked were selected and circled. Human iPS cells 
were prepared for sub-culture by aspirating the media and rinsing the plate 
with PBS. BD Dispase (5 mL for 10 cm dish, or 3 mL for 6 cm dish) was added 
and incubated for 10 minutes or until cells appear to be lifting off from the 
plate. BD Dispase was then diluted by adding an equal volume of PBS. The 
cells were scraped using a glass pipet, or each colony was picked with a p200 
pipet and placed in an Eppendorf® tube. DMEM F-12 (1 mL) was added to 
each tube followed by 200 μl of Accumax™ (Accumax added after all colonies 
have been picked and tubes are ready to spin). The cells were spun immediately 
at 800 rpm for 5 minutes. The colony was resuspended in 0.5 mL of mTeSR®1 
+ Rock inhibitor (1 μl/mL) and plated on a 48-or 24-well plate (depending on 
size of the colony) coated with BD Matrigel hESC-qualifi ed matrix and fed 
every day. Rock inhibitor was left in culture for one day after passage.
Culture of Picked Clones
The iPSC clone C139 derived from human myoblasts was then maintained on 
BD Matrigel hESC-qualifi ed matrix-coated BD Falcon™ multiwell plates in 
mTeSR1 media. Cells were passaged using Accumax at a 1:4-1:6 split ratio. 
Media was changed every day during one passage cycle, except once per week 
when a double volume of media was added to skip changing media on one day. 
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Feeding Human iPS Cells
The iPS cells were monitored and fed daily until the cells required passaging. 
The spent medium was aspirated with a sterile Pasture pipet and 3.0 mL of 
fresh mTeSR® medium was added to each well of a 6-well BD Matrigel™ 
hESC-qualifi ed matrix-coated plate and incubated at 37°C. To reduce 
potential contamination, pipets or Pasteur pipets were used only once.
Passaging iPS Cells 
The cells were split when one of the following was observed: 
1. iPSC colonies are becoming too large or too dense.
2. Increased differentiation.
The split ratio is variable, but generally between 1:3 and 1:9. The split ratio 
was adjusted depending on the growth rate of cells.
Cells grown on BD Matrigel hESC-qualifi ed matrix and mTeSR were always 
passaged with Accumax™. Accumax (0.5 mL) was directly added to the cells 
after removing the media. The cells were monitored closely since Accumax is a 
very powerful disaggregating agent (usually the incubation time with 
Accumax is about 5 minutes). The cell suspension was transferred to a tube 
containing culture media at 5X the volume of Accumax reagent used (DMEM 
F-12 media or variants like IMDM, DMEM, etc). Immediately after diluting 
the Accumax, the cells were briefl y agitated by gentle pipetting, and were spun 
at 800 rpm for 5 minutes. The cells were resuspended in mTeSR + Rock 
inhibitor (1 μl/mL) and replated in a plate previously coated with BD Matrigel 
hESC-qualifi ed matrix. Cells grown in BD Matrigel hESC-qualifi ed matrix 
and mTeSR generally need to be split every 3-5 days.
Immunocytochemical Detection of Embryonic Antigens in iPS cells 
Human iPS cells cultured on BD Matrigel hESC-qualifi ed matrix and mTeSR 
were analysed for the expression of undifferentiated markers on the cells. The 
iPS cells were fi xed with 4% paraformaldehyde (prepared fresh in PBS) for 20 
minutes at room temperature and washed 3 times with PBS for 5 minutes. For 
Specifi c Embryonic Antigen 4 (SSEA-4), TRA-1-60 and Alkaline Phosphatase 
(AP) staining, the cells were blocked with 1% BSA, and 10% normal donkey 
serum in PBS (blocking buffer) at room temperature for 45 minutes. For 
Oct-3/4 and Nanog staining, the cells were permeabilized prior to staining 
with antibodies for intracellular markers and blocked with 0.1% Triton™ 
X-100, 1% BSA, and 10% normal donkey serum in PBS at room temperature 
for 45 minutes. After blocking, cells were probed with anti-SSEA-4, Oct-3/4, 
Nanog, AP, and TRA-1-60 primary antibody at a fi nal concentration of 10 μg/
mL and incubated overnight at 2-8°C. The cells were washed three times with 
2 mL of PBS containing 1% BSA for 5 minutes. After washing, the cells were 
incubated with Alexa Fluor®-conjugated secondary antibody (Alexa Fluor 555 
donkey anti-goat IgG, or goat anti-mouse IgG) diluted 1:1000 in PBS 
containing 1% BSA for 60 minutes at room temperature in the dark. The cells 
were then washed three times with PBS containing 1% BSA for 5 minutes. 
Nuclei were counterstained with 4,6-Diamidino-2-phenylindole (DAPI, 0.1 μg/
mL). The plates were stored wrapped in aluminum foil at 4°C in 2 mL PBS 
until visualized under a fl uorescence microscope.
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Teratoma Formation
Human iPS cells were cultured for 15-20 passages on BD Matrigel™ hESC-
qualifi ed matrix-coated culture dishes in mTeSR media and subsequently 
tested for pluripotency by teratoma formation. Cells were injected into the 
hind leg muscle of immunodefi cient mice. BD Matrigel matrix was added at 
1/3 total volume to the cell suspension prior to injection. Tumors formed at 6 
weeks post-injection were processed for hematoxylin and eosin staining and 
histological analysis.
Results and Discussion
Morphology of Human iPS Cells cultured on Mouse Embryonic Fibroblast 
Feeder Layer, and on BD Matrigel matrix in a Feeder-free Culture System
Colonies displaying hESC morphology were expanded on MEFs (after the 
completion of infection), and the clones were successfully maintained under 
feeder-free conditions using BD Matrigel hESC-qualifi ed matrix-coated 
surface and mTeSR®1 media. Figure 1 (A-D) shows representative examples of 
healthy human iPSC colonies that are good candidates for selection from the 
MEF layer. The cells in these colonies exhibit ES-like morphology. Once clear 
colonies appeared on the MEF layer, they were picked to establish a clonal 
population and then maintained under feeder-free culture conditions. 
Disclaimer
Figure 1. Phase contrast micrographs showing representative examples of human iPSC colonies 
on MEF feeder layer that are suitable for selection. Magnification: A and B (4X); C and D (20X). 
D
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Figure 2 (A-D) represents phase contrast micrographs showing the morphology 
of good human iPSC clones cultured on BD Matrigel™ hESC-qualifi ed matrix-
coated surface. The cells have formed densely packed colonies, and the individual 
cells had a high nuclear to cytoplasmic ratio, as well as a prominent single 
nucleolus that is typical of human ES cells. Furthermore, the colonies exhibit 
features indicative of pluripotency, such as sharply defi ned edges and round, 
three-dimensional colony morphology.
Immunocytochemical Analysis of Human iPS Cells for Undifferentiated Cells
To confirm their ability to express ES cell proteins, human iPS cells were 
immunostained with antibodies directed against AP, SSEA-4, Oct-3/4, TRA-1-
60, and Nanog. Consistent with their hES cell-like morphology, iPS cells 
maintained on BD Matrigel hESC-qualifi ed matrix expressed characteristic 
markers for undifferentiated cells, including Nanog, Oct-3/4, TRA-1-60, SSEA-
4, and AP (Figure 3). 
Disclaimer
Figure 2. Representative images of human iPS cells cultured on feeder-free BD Matrigel hESC-
qualified matrix-coated surface and mTeSR®1 media. Phase contrast micrographs showing the 
morphology of human iPSC clones. Magnification: A (5X); B (10X); C (20X); and D (35X).
A B
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As anticipated, expression of SSEA-1 was not detectable (data not shown). 
Corresponding images stained with DAPI show nuclei of individual cells in the 
colonies (Figure 3, Panel B). Panels C and D are merge of images in (A) and (B). 
These results demonstrate that human iPS cells can be readily maintained under 
feeder-free conditions and reduce variability associated with feeder cells.
Disclaimer
Figure 3. Immunocytochemistry of human iPSC cells expressing markers of undifferentiated cells. Human iPS cells maintained pluripotency on 
BD Matrigel hESC-qualified matrix-coated surface after 10 passages. The iPS cells were stained using antibodies directed against Nanog, AP, 
Oct 3/4, SSEA-4, and TRA-1-60 (red; Panel A), and the nuclei were counterstained with 4,6-Diamidino-2-phenylindole (DAPI) (blue; Panel B) 
to indicate the total cell content per field. Panels C and D are merged images of Panels A and B Magnification: Panels A-C (10X); Panel D (20X).
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Human iPS cell Differentiation
The teratoma assay is routinely used to demonstrate the pluripotency of newly 
established hPSC lines, long-term cultures, and genetically modifi ed hPSCs. To 
further establish pluripotency of human iPS cells on a functional level in vivo, 
the teratoma differentiation assay was performed. Representative results 
(Figure 4) demonstrate that hiPSCs maintained in BD Matrigel™ hESC-
qualifi ed matrix and mTeSR®1 for multiple passages are capable of forming 
teratomas 6 weeks post-injection into immunocompromised mice, and 
differentiated into cells derived from all three germ layers.
We have successfully cultured human iPS cells in BD Matrigel hESC-qualifi ed 
matrix and mTeSR media. Furthermore, human iPS cells cultured from frozen 
stocks expressed pluripotency markers when maintained on BD Matrigel hESC-
qualifi ed matrix and mTeSR media. All of the ES like characteristics of the human 
iPSC clones were maintained after multiple freezing (data not shown).
Conclusions
BD Matrigel matrix is an effective surface that supports feeder-free expansion 
and maintenance of undifferentiated human iPS cells. Collectively, our 
analyses demonstrate the successful maintenance of human iPS cells on 
BD Matrigel hESC-qualifi ed matrix under feeder-free conditions, which 
potentially reduces the variability associated with using mouse feeder cells. 
Human iPSC cultures exhibited normal morphology, expressed markers of 
undifferentiated human iPS cells, and differentiated into all three germ layers.
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Figure 4. Representative images demonstrating 
iPS cells cultured on BD Matrigel hESC-
qualified matrix form teratomas after 6 weeks 
post-injection, and differentiate into all three 
embryonic germ layers including ectoderm, 
mesoderm, and endoderm as indicated by 
hematoxylin and eosin staining of paraffin 
sections through teratomas. Magnification: 5X.
